108 related articles for article (PubMed ID: 6126089)
21. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
Weber M; Meyer F; Halloul Z
Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
[TBL] [Abstract][Full Text] [Related]
22. [Infection of bones and joints].
Burri C; Neugebauer R
Aktuelle Probl Chir Orthop; 1989; 34():1-110. PubMed ID: 2564744
[No Abstract] [Full Text] [Related]
23. [Intravenous and intraperitoneal administration of an antiseptic: 65 cases of diffuse peritonitis treated with taurolin].
Marti MC; Moser G; Wicki O; Linder M; del Ponte F
Helv Chir Acta; 1980 Feb; 46(5-6):755-8. PubMed ID: 7399955
[No Abstract] [Full Text] [Related]
24. [Tauroline in peritonitis].
Wicki O; Pfirrmann RW
Aktuelle Probl Chir Orthop; 1979; (12):42-8. PubMed ID: 36795
[No Abstract] [Full Text] [Related]
25. C controlled trial of taurolin in established bacterial peritonitis.
Browne MK; MacKenzie M; Doyle PJ
Surg Gynecol Obstet; 1978 May; 146(5):721-4. PubMed ID: 347606
[TBL] [Abstract][Full Text] [Related]
26. [Indication and use of Septopal in chronic osteitis (author's transl)].
Weise K; Weller S
Aktuelle Traumatol; 1980 Apr; 10(2):57-64. PubMed ID: 6107014
[TBL] [Abstract][Full Text] [Related]
27. [Pleural empyema and Tauroflex. Study of a new bactericidal agent].
Marti MC; Moser G; Bordigoni P
Schweiz Med Wochenschr; 1978 Feb; 108(6):215-6. PubMed ID: 341304
[TBL] [Abstract][Full Text] [Related]
28. [Appendicular peritonitis: comparative study of antibiotic therapy and a topical bactericidal agent].
Marti MC; Moser G
Helv Chir Acta; 1980 Sep; 47(3-4):463-7. PubMed ID: 7193668
[TBL] [Abstract][Full Text] [Related]
29. The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin.
Knight BI; Skellern GG; Browne MK; Pfirrmann RW
Br J Clin Pharmacol; 1981 Sep; 12(3):439-40. PubMed ID: 7295478
[No Abstract] [Full Text] [Related]
30. [Nebacetin and taurolin as intraoperative disinfectant solutions in surgery of the locomotor system (author's transl)].
Burri C; Lob G; Rudzki M
Aktuelle Traumatol; 1980 Apr; 10(2):65-72. PubMed ID: 6107015
[TBL] [Abstract][Full Text] [Related]
31. Challenges in ocular infectious diseases and the evolution of anti-infective therapy.
Oguz E; Oguz H
Surv Ophthalmol; 2004; 49(6):617-8; author reply 618. PubMed ID: 15530948
[No Abstract] [Full Text] [Related]
32. [A new surgical lavage].
Bühler HU; Mikic St; Wicki O
Helv Chir Acta; 1978 May; 45(1-2):143-5. PubMed ID: 659232
[TBL] [Abstract][Full Text] [Related]
33. [The therapy of the postextraction syndrome with Taurolin. A controlled clinical study].
Zimmermann M; Nentwig GH
Schweiz Monatsschr Zahnmed; 1992; 102(11):1327-32. PubMed ID: 1470889
[TBL] [Abstract][Full Text] [Related]
34. Taurolin, a new chemotherapeutic agent.
Browne MK; Leslie GB; Pfirrmann RW
J Appl Bacteriol; 1976 Dec; 41(3):363-8. PubMed ID: 828157
[No Abstract] [Full Text] [Related]
35. Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis.
Knight BI; Skellern GG; Browne MK; Pfirrmann RW
Br J Clin Pharmacol; 1981 Nov; 12(5):695-9. PubMed ID: 7332737
[TBL] [Abstract][Full Text] [Related]
36. The rate of antimicrobial action of noxythiolin and taurolin.
Brearley S; George RH
J Hosp Infect; 1980 Sep; 1(3):201-9. PubMed ID: 6182213
[No Abstract] [Full Text] [Related]
37. [The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis].
Billing A; Fröhlich D; Ruckdeschel G
Langenbecks Arch Chir; 1992; 377(3):180-5. PubMed ID: 1619980
[TBL] [Abstract][Full Text] [Related]
38. The anti-endotoxin activity of Taurolin in experimental animals.
Pfirrmann RW; Leslie GB
J Appl Bacteriol; 1979 Feb; 46(1):97-102. PubMed ID: 374333
[No Abstract] [Full Text] [Related]
39. Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent.
Gorman SP; McCafferty DF; Woolfson AD; Jones DS
J Appl Bacteriol; 1987 Apr; 62(4):315-20. PubMed ID: 3298185
[TBL] [Abstract][Full Text] [Related]
40. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
Koldehoff M; Zakrzewski JL
Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
